Literature DB >> 18588864

[+]-Huperzine A treatment protects against N-methyl-D-aspartate-induced seizure/status epilepticus in rats.

Brian R Coleman1, Ruthie H Ratcliffe, Samuel A Oguntayo, Xuerong Shi, Bhupendra P Doctor, Richard K Gordon, Madhusoodana P Nambiar.   

Abstract

The toxicity of organophosphorous (OP) nerve agents is attributed to their irreversible inhibition of acetylcholinesterase (AChE), which leads to excessive accumulation of acetylcholine (ACh) and is followed by the release of excitatory amino acids (EAA). EAAs sustain seizure activity and induce neuropathology due to over-stimulation of N-methyl-d-aspartate (NMDA) receptors. Huperzine A (Hup A), a blood-brain barrier permeable selective reversible inhibitor of AChE, has been shown to reduce EAA-induced cell death by interfering with glutamate receptor-gated ion channels in primary neuronal cultures. Although [-]-Hup A, the natural isomer, inhibits AChE approximately 38-fold more potently than [+]-Hup A, both [-]- and [+]-Hup A block the NMDA channel similarly. Here, we evaluated the protective efficacy of [+]-Hup A for NMDA-induced seizure in a rat model. Rats implanted with radiotelemetry probes to record electroencephalography (EEG), electrocardiography (ECG), body temperature, and physical activity were administered various doses of [+]-Hup A (intramuscularly) and treated with 20 microg/kg NMDA (intracerebroventricular) 20-30 min later. For post-exposure, rats were treated with [+]-Hup A (3 mg/kg, intramuscularly) 1 min after NMDA (20 microg/kg). Our data showed that pre- and post-exposure, [+]-Hup A (3 mg/kg) protects animals against NMDA-induced seizures. Also, NMDA-administered animals showed increased survival following [+]-Hup A treatment. [+]-Hup A has no visible effect on EEG, heart-rate, body temperature, or physical activity, indicating a reduced risk of side effects, toxicity, or associated pathology. Our results suggest that [+]-Hup A protects against seizure and status epilepticus (SE) by blocking NMDA-induced excitotoxicity in vivo. We propose that [+]-Hup A, or a unique combination of [+]- and [-]-Hup A, may prove to be effective for pre- and post-exposure treatment of lethal doses of OP-induced neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18588864     DOI: 10.1016/j.cbi.2008.05.023

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  11 in total

1.  [+]-Huperzine A protects against soman toxicity in guinea pigs.

Authors:  Ying Wang; Yanling Wei; Samuel Oguntayo; Neil Jensen; Bhupendra P Doctor; Madhusoodana P Nambiar
Journal:  Neurochem Res       Date:  2011-08-07       Impact factor: 3.996

2.  Pharmacokinetics and tolerability of oral dosage forms of huperzine a in healthy Chinese male volunteers: a randomized, single dose, three-period, six-sequence crossover study.

Authors:  San-Lan Wu; Jun Gan; Jing Rao; Si-Jie He; Wen-Wen Zhu; Ying Zhao; Yong-Ning Lv; Jian-Geng Huang; Ya-Ni Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-10-20

3.  Large-Scale Phenotype-Based Antiepileptic Drug Screening in a Zebrafish Model of Dravet Syndrome

Authors:  Matthew T Dinday; Scott C Baraban
Journal:  eNeuro       Date:  2015-08-31

4.  Huperzine A Provides Robust and Sustained Protection against Induced Seizures in Scn1a Mutant Mice.

Authors:  Jennifer C Wong; Stacey B B Dutton; Stephen D Collins; Steven Schachter; Andrew Escayg
Journal:  Front Pharmacol       Date:  2016-10-17       Impact factor: 5.810

Review 5.  Chinese Herbal Medicine Interventions in Neurological Disorder Therapeutics by Regulating Glutamate Signaling.

Authors:  Yan Liu; Shan Wang; Jun Kan; Jingzhi Zhang; Lisa Zhou; Yuli Huang; Yunlong Zhang
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

6.  Donepezil increases resistance to induced seizures in a mouse model of Dravet syndrome.

Authors:  Jennifer C Wong; Jacquelyn T Thelin; Andrew Escayg
Journal:  Ann Clin Transl Neurol       Date:  2019-07-23       Impact factor: 4.511

7.  Advances in toxicology and medical treatment of chemical warfare nerve agents.

Authors:  Mohammd Moshiri; Emadodin Darchini-Maragheh; Mahdi Balali-Mood
Journal:  Daru       Date:  2012-11-28       Impact factor: 3.117

8.  Recent advances in the treatment of organophosphorous poisonings.

Authors:  Mahdi Balali-Mood; Hamidreza Saber
Journal:  Iran J Med Sci       Date:  2012-06

9.  Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease.

Authors:  Angel Agis-Torres; Monica Sölhuber; Maria Fernandez; J M Sanchez-Montero
Journal:  Curr Neuropharmacol       Date:  2014-01       Impact factor: 7.363

Review 10.  The pharmacology and therapeutic potential of (-)-huperzine A.

Authors:  Maung Kyaw Moe Tun; Seth B Herzon
Journal:  J Exp Pharmacol       Date:  2012-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.